Department of Health and Human Services September 4, 2024 – Federal Register Recent Federal Regulation Documents
Results 1 - 16 of 16
Statement of Organization, Functions, and Delegations of Authority
This notice announces revisions to the organizations within the Administration for Strategic Preparedness and Response (ASPR).
Solicitation of Nominations for Membership To Serve on the Advisory Commission on Childhood Vaccines
HRSA is seeking nominations of qualified candidates to consider for appointment as members of the Advisory Commission on Childhood Vaccines (ACCV or Commission). ACCV advises the Secretary of HHS (the Secretary) on issues related to the implementation of the National Vaccine Injury Compensation Program (VICP).
Proposed Information Collection Activity; State Self-Assessment Review and Report (Office of Management and Budget No.: 0970-0223)
The Administration for Children and Families (ACF), Office of Child Support Services (OCSS), is requesting the Office of Management and Budget (OMB) to approve the State Self-Assessment Review and Report (SARR) (OMB#: 0970-0223) for an additional three years with revisions to the instrument reflecting the name change from the Office of Child Support Enforcement to the Office of Child Support Services. The information collected in the reports helps state child support agencies and OCSS determine whether the agencies meet federal child support performance requirements. The current OMB approval expires on May 31, 2025.
Determination That FLAGYL (Metronidazole) Tablets, 250 Milligrams and 500 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA or Agency) has determined that FLAGYL (metronidazole) tablets, 250 milligrams (mg) and 500 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to these products as long as they meet relevant legal and regulatory requirements.
Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
Submission for Office of Management and Budget Review; Tribal Maternal, Infant, and Early Childhood Home Visiting Program: Guidance for Submitting an Annual Report to the Secretary (Office of Management and Budget#: 0970-0409)
The Administration for Children and Families (ACF), Early Childhood Development (ECD) is requesting revisions to the Tribal Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program: Guidance for Submitting Reports (Office of Management and Budget (OMB) #: 0970-0409; expiration 3/31/2026) and a three-year extension of approval.
Meeting of the Advisory Committee on Infant and Maternal Mortality
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Infant and Maternal Mortality (ACIMM or Committee) has scheduled a public meeting. Information about ACIMM and the agenda for this meeting can be found on the ACIMM website at https://www.hrsa.gov/advisory-committees/infant- mortality/.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
